New therapies, screening interventions provide hope for progress

January 14, 2023

1 minute read

We were unable to process your request. Please try again later. If you continue to have this problem, please contact [email protected]

Cervical Cancer Awareness Month is observed every January.

An estimated 14,100 new cases of invasive cervical cancer are diagnosed in the United States each year, and about 4,280 women will die from the disease this year, according to the American Cancer Society.

SEM image of cervical cancer cell.

Cervical Cancer Awareness Month helps educate the public about malignancy, which is highly preventable through HPV vaccination and appropriate screening.

In conjunction with the observation, Healio provides the following updates in the prevention, screening, diagnosis and treatment of cervical cancer.

1. The treatment of advanced, recurrent and metastatic cervical cancer has come a long way in the past 15 years, and data on new combinations and therapies provide hope for further progress, according to a speaker at the Chemotherapy Foundation Symposium. Read more.

2. Remote interventions have led to higher screening rates for cervical cancer and other malignancies among women living in rural areas. Read more.

3. Minimally invasive surgery conferred lower survival rates than open surgery among women with cervical cancer, Phase 3 study results showed. Read More

4. Assessment of sexual function occurred much less often among women receiving brachytherapy for cervical cancer than in men receiving internal radiation therapy for prostate cancer. Read more.

5. Atezolizumab (Tecentriq, Genentech) given before and during chemoradiotherapy appeared safe and demonstrated immunomodulatory activity among women with locally advanced nodal cervical cancer. Read more.

6. Rates of distant-stage cervical cancer increased among some women in the United States between 2001 and 2018. At the same time, rates of early-stage cervical cancer decreased. Read more.

7. Individuals who identified as a sexual minority were less likely to have a Pap smear than heterosexual individuals. The findings appeared consistent across specific sexual minority groups. Read more.

8. A decrease in US cervical cancer rates among younger women could be associated with the approval of HPV vaccination. Read more.


Add a Comment

Your email address will not be published. Required fields are marked *